NCT01937390 - Observational Study of Adherence to LABA / LAMA in Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter

Enrollment

645

Participants

Timeline

Start Date

November 6, 2011

Primary Completion Date

October 22, 2016

Study Completion Date

October 22, 2016

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Tiotropium 2x2.5µg tiotropium (equivalent to 2x3.154µg tiotropium bromide monohydrate) Respimat® inhaler and cartridge Solution for inhalation

Respimat® inhaler and cartridge Solution for inhalation

DRUG

Indacterol 300 µg

inhalation powder

DRUG

Tiotropium 18µg (equivalent to 22.5µg tiotropium bromide monohydrate) HandiHaler® device Inhalation powder, hard capsule

HandiHaler® device Inhalation powder, hard capsule

DRUG

Indacterol 150 µg

inhalation powder

Trial Locations (1)

CTMS MIGRATION CENTER representing all obvious CTMS Dummy Sites, Ingelheim